Merck and NanoString Technologies, Inc. today announced a clinical research collaboration to develop an assay that will optimize immune-related gene expression signatures.
BUSINESS WIRE
Advertisement
Articles by BUSINESS WIRE
Multiple Sclerosis patient Jack Osbourne unveils new resources to empower others with Multiple Sclerosis to take a more active role in managing disease.
Advertisement
Latest Updated Articles
- Jack Osbourne and Teva Launch Enhanced You Don't Know Jack About MS® Website Featuring New Multimedia Content
Published: May 27th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Regular Melatonin Supplementation May Hide Hidden Heart Complications
2
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
3
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
4
COVID-19 During Pregnancy Raises Neurodevelopmental Risks in Children
5
